1109 related articles for article (PubMed ID: 10487660)
1. Elevated serum levels of free insulin-like growth factor I in polycystic ovary syndrome.
Thierry van Dessel HJ; Lee PD; Faessen G; Fauser BC; Giudice LC
J Clin Endocrinol Metab; 1999 Sep; 84(9):3030-5. PubMed ID: 10487660
[TBL] [Abstract][Full Text] [Related]
2. Insulin, somatotropic, and luteinizing hormone axes in lean and obese women with polycystic ovary syndrome: common and distinct features.
Morales AJ; Laughlin GA; Bützow T; Maheshwari H; Baumann G; Yen SS
J Clin Endocrinol Metab; 1996 Aug; 81(8):2854-64. PubMed ID: 8768842
[TBL] [Abstract][Full Text] [Related]
3. Metabolic features of polycystic ovary syndrome are found in adolescent girls with hyperandrogenism.
Apter D; Bützow T; Laughlin GA; Yen SS
J Clin Endocrinol Metab; 1995 Oct; 80(10):2966-73. PubMed ID: 7559882
[TBL] [Abstract][Full Text] [Related]
4. Plasma levels of insulin-like growth factor-I and its binding protein in polycystic ovary syndrome.
Iwashita M; Mimuro T; Watanabe M; Setoyama T; Matsuo A; Adachi T; Takeda Y; Sakamoto S
Horm Res; 1990; 33 Suppl 2():21-6. PubMed ID: 1710201
[TBL] [Abstract][Full Text] [Related]
5. Serum anti-Müllerian hormone levels remain high until late reproductive age and decrease during metformin therapy in women with polycystic ovary syndrome.
Piltonen T; Morin-Papunen L; Koivunen R; Perheentupa A; Ruokonen A; Tapanainen JS
Hum Reprod; 2005 Jul; 20(7):1820-6. PubMed ID: 15802325
[TBL] [Abstract][Full Text] [Related]
6. Ovarian follicular development and the follicular fluid hormones and growth factors in normal women of advanced reproductive age.
Klein NA; Battaglia DE; Miller PB; Branigan EF; Giudice LC; Soules MR
J Clin Endocrinol Metab; 1996 May; 81(5):1946-51. PubMed ID: 8626862
[TBL] [Abstract][Full Text] [Related]
7. Circulating levels of insulin-like growth factor (IGF) binding protein-1 and -3 in aging men: relationships to insulin, glucose, IGF, and dehydroepiandrosterone sulfate levels and anthropometric measures.
Benbassat CA; Maki KC; Unterman TG
J Clin Endocrinol Metab; 1997 May; 82(5):1484-91. PubMed ID: 9141538
[TBL] [Abstract][Full Text] [Related]
8. Serum and follicular fluid levels of insulin-like growth factor I (IGF-I), IGF-II, and IGF-binding protein-1 and -3 during the normal menstrual cycle.
Thierry van Dessel HJ; Chandrasekher Y; Yap OW; Lee PD; Hintz RL; Faessen GH; Braat DD; Fauser BC; Giudice LC
J Clin Endocrinol Metab; 1996 Mar; 81(3):1224-31. PubMed ID: 8772603
[TBL] [Abstract][Full Text] [Related]
9. Disruption of the synchronous secretion of leptin, LH, and ovarian androgens in nonobese adolescents with the polycystic ovarian syndrome.
Veldhuis JD; Pincus SM; Garcia-Rudaz MC; Ropelato MG; Escobar ME; Barontini M
J Clin Endocrinol Metab; 2001 Aug; 86(8):3772-8. PubMed ID: 11502810
[TBL] [Abstract][Full Text] [Related]
10. Amplified and orderly growth hormone secretion characterizes lean adolescents with polycystic ovary syndrome.
Garcia-Rudaz MC; Ropelato MG; Escobar ME; Veldhuis JD; Barontini M
Eur J Endocrinol; 2002 Aug; 147(2):207-16. PubMed ID: 12153742
[TBL] [Abstract][Full Text] [Related]
11. Polycystic ovarian syndrome: evidence that flutamide restores sensitivity of the gonadotropin-releasing hormone pulse generator to inhibition by estradiol and progesterone.
Eagleson CA; Gingrich MB; Pastor CL; Arora TK; Burt CM; Evans WS; Marshall JC
J Clin Endocrinol Metab; 2000 Nov; 85(11):4047-52. PubMed ID: 11095431
[TBL] [Abstract][Full Text] [Related]
12. The insulin-sensitizing agent troglitazone improves metabolic and reproductive abnormalities in the polycystic ovary syndrome.
Dunaif A; Scott D; Finegood D; Quintana B; Whitcomb R
J Clin Endocrinol Metab; 1996 Sep; 81(9):3299-306. PubMed ID: 8784087
[TBL] [Abstract][Full Text] [Related]
13. Increased insulin-like growth factor-I levels in women with polycystic ovary syndrome, and beneficial effects of metformin therapy.
Berker B; Emral R; Demirel C; Corapcioglu D; Unlu C; Kose K
Gynecol Endocrinol; 2004 Sep; 19(3):125-33. PubMed ID: 15697073
[TBL] [Abstract][Full Text] [Related]
14. Serum leptin levels in women with polycystic ovary syndrome: the role of insulin resistance/hyperinsulinemia.
Laughlin GA; Morales AJ; Yen SS
J Clin Endocrinol Metab; 1997 Jun; 82(6):1692-6. PubMed ID: 9177365
[TBL] [Abstract][Full Text] [Related]
15. Metformin therapy increases insulin-like growth factor binding protein-1 in hyperinsulinemic women with polycystic ovary syndrome.
Pawelczyk L; Spaczynski RZ; Banaszewska B; Duleba AJ
Eur J Obstet Gynecol Reprod Biol; 2004 Apr; 113(2):209-13. PubMed ID: 15063962
[TBL] [Abstract][Full Text] [Related]
16. Glucose intolerance, insulin resistance, and hyperandrogenemia in first degree relatives of women with polycystic ovary syndrome.
Yildiz BO; Yarali H; Oguz H; Bayraktar M
J Clin Endocrinol Metab; 2003 May; 88(5):2031-6. PubMed ID: 12727950
[TBL] [Abstract][Full Text] [Related]
17. Vascular endothelial growth factor and insulin-like growth factor-1 in polycystic ovary syndrome and their relation to ovarian blood flow.
Abd El Aal DE; Mohamed SA; Amine AF; Meki AR
Eur J Obstet Gynecol Reprod Biol; 2005 Feb; 118(2):219-24. PubMed ID: 15653207
[TBL] [Abstract][Full Text] [Related]
18. Inappropriate gonadotropin secretion in polycystic ovary syndrome: influence of adiposity.
Arroyo A; Laughlin GA; Morales AJ; Yen SS
J Clin Endocrinol Metab; 1997 Nov; 82(11):3728-33. PubMed ID: 9360532
[TBL] [Abstract][Full Text] [Related]
19. [Serum levels of anti-muller hormone in women with polycystic ovary syndrome and healthy women of reproductive age].
Parahuleva N; Pehlivanov B; Orbecova M; Deneva T; Uchikova E
Akush Ginekol (Sofiia); 2013; 52 Suppl 1():16-23. PubMed ID: 24294740
[TBL] [Abstract][Full Text] [Related]
20. Diurnal variation of sex hormone binding globulin and insulin-like growth factor binding protein-1 in women with polycystic ovary syndrome.
Hamilton-Fairley D; White D; Griffiths M; Anyaoku V; Koistinen R; Seppälä M; Franks S
Clin Endocrinol (Oxf); 1995 Aug; 43(2):159-65. PubMed ID: 7554310
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
